PBM reform dropped in Congress' funding package
pharmaphorum
DECEMBER 22, 2024
Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government
pharmaphorum
DECEMBER 22, 2024
Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government
Cloudbyz
DECEMBER 22, 2024
Cloudbyz Earns Dual Recognition in Everest Groups 2024 PEAK Matrix for CTMS and EDC Solutions Driving Innovation in Clinical Trial Management Cloudbyz is proud to announce its dual recognition in Everest Groups 2024 PEAK Matrix assessments for both Clinical Trial Management System (CTMS) and Electronic Data Capture (EDC) solutions. This achievement solidifies Cloudbyzs position as a trusted partner in advancing clinical research through cutting-edge, cloud-based technologies.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 22, 2024
Ionis Pharma's Tryngolza (olezarsen) has become the first FDA-approved drug therapy for adults with rare disease familial chylomicronaemia syndrome
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 22, 2024
Avocados made the cut. (coyot/Pixabay) The United States has redefined what qualifies as “healthy” food for the first time in 30 years, striking items like white bread from the list while welcoming nutrient-rich options such as eggs and salmon, officials said Thursday.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
DECEMBER 22, 2024
Novo Nordisk data on obesity candidate CagriSema falls short of expectations, wiping around $94 billion off its market valuation.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 22, 2024
The life sciences sector has witnessed significant transformation driven by advancements in infrastructure, technology, and accessibility. These cover from genetic testing and precision medicine to the growing integration of generative AI in various aspects of healthcare.
Let's personalize your content